IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
15.65
-0.04 (-0.25%)
Nov 5, 2024, 12:44 PM EST - Market open
IGM Biosciences Analyst Ratings
Total Analysts
8
Consensus Rating
Hold
Price Target
$14.38
Upside
-8.12%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $17 → $20 | Buy | Maintains | $17 → $20 | +27.80% | Oct 18, 2024 |
| Wedbush | Wedbush | Buy Maintains $25 → $22 | Buy | Maintains | $25 → $22 | +40.58% | Oct 1, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $20 → $17 | Buy | Maintains | $20 → $17 | +8.63% | Oct 1, 2024 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades $12 → $9 | Hold → Sell | Downgrades | $12 → $9 | -42.49% | Oct 1, 2024 |
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades $24 → $12 | Strong Buy → Hold | Downgrades | $24 → $12 | -23.32% | Oct 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $12 → $11 | Hold | Maintains | $12 → $11 | -29.71% | Sep 5, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $25 → $24 | Strong Buy | Maintains | $25 → $24 | +53.35% | Aug 23, 2024 |
| Wedbush | Wedbush | Buy Maintains $20 → $25 | Buy | Maintains | $20 → $25 | +59.74% | Aug 15, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $20 | Buy | Reiterates | $20 | +27.80% | Aug 15, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $11 → $12 | Hold | Maintains | $11 → $12 | -23.32% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $12 | Hold | Reiterates | $12 | -23.32% | May 24, 2024 |
| Wedbush | Wedbush | Buy Reiterates $20 | Buy | Reiterates | $20 | +27.80% | May 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $12 | Hold | Reiterates | $12 | -23.32% | Apr 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $7 → $12 | Hold | Maintains | $7 → $12 | -23.32% | Mar 12, 2024 |
| Wedbush | Wedbush | Buy Reiterates $20 | Buy | Reiterates | $20 | +27.80% | Mar 8, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $21 | Buy | Reiterates | $21 | +34.19% | Mar 8, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.